Thus, the variants influencing the risk of developing PPMS and controlling DNA methylation in the 1q21.1 locus likely also exert an effect on the expression of proximal genes in the brain, particularly CHD1L, FMO5, and PRKAB2. This evidence concerns the gene FMO5 and primary progressive multiple sclerosis.